This stock is having a strong session. Let's see what is getting investors excited. The post Why is this ASX rare earths stock storming 7% higher today? appeared first on The Motley Fool Australia.

Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...

You don't need a large outdoor space to create a charming garden. These small garden ideas will inspire an upgrade to your ...

What it is. AXPAXLI (OTX-TKI) is an investigational, bioresorbable intravitreal hydrogel implant designed to continuously ...

After completing a critical phase of her medical treatment, the Princess of Wales has entered a new chapter defined by a ...

Medium-dose OCU410 met the 12-month primary endpoint, reducing GA lesion growth by 31% versus control (P < .05), with ...

Iran and Israel traded strikes on Tuesday as the war showed no sign of de-escalation despite Trump signalling "very good ...

The final line-up for the 2026 World Cup will be decided over the next week, with 16 teams competing for the last four places ...

Innovent Biologics’ eye disease prospect has matched Bayer and Regeneron’s Eylea in a phase 3 study, teeing up filings for ...

Scientists reveal why mint creates a cooling sensation without lowering body temperature by activating a key sensor in the ...

Prediction markets signal a higher-for-longer Fed outlook after Powell’s decision—see Kalshi odds for December rate levels ...

RIPE Project/Claire Benjamin (photographer), licensed under CC BY 4.0. It seems imperative, then, that we better understand ...